Botanical and Plant-Derived Drug Industry to Blossom

The global botanical and plant-derived drug market is expected to blossom by 2013, reaching a combined total of $32.9 billion a compound annual growth rate (CAGR) of 11%, according to a new study by BCC Research (Wellesley, MA). That is an increase from $19.5 billion last year, it adds Botanical drugs are those that are FDA approved under the botanical drug pathway; plant-derived drugs are those under a new FDA classification that are botanicals and contain a mixture of plant-derived and synthetic substances, BCC says. The plant-derived drug sector commands the...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers